Immune checkpoint inhibitors (ICIs) are essential for urothelial carcinoma (UC) treatment. Fibroblast growth factor receptor (FGFR) alterations. as common oncogenic drivers in UC. have been reported to drive T cell depletion of UC immune microenvironment via up-regulating FGFR signaling. https://parisnaturalfoodes.shop/product-category/post-rx-blue-raspberry/